NIH director Dr. Francis Collins recently made another stop on his “Gratitude Tour.” He has visited several key staff and locations in 2021 to show his appreciation for employees and their continuous high-quality efforts in the midst of unprecedented, pandemic conditions.
Dr. Kaitlyn Sadtler set up her NIH lab, ready to study ways to regenerate injured tissues. She soon made a hard pivot when the pandemic hit, leading a serology study to help gauge asymptomatic, undiagnosed Covid infections around the country.
Vision impairment is a common feature in most individuals with albinism, a condition in which the skin, hair and eyes (or some combination of the three) have reduced melanin pigmentation. Problems with eyesight can be so severe that people may be declared legally blind. Dr. Brian P. Brooks of NEI is investigating therapies to improve vision quality in patients with oculocutaneous albinism (OCA), which is the most common form of albinism in the U.S.
Two investigators made bold predictions about race and ancestry during a recent NHGRI human genomics seminar.
On the Cover
Myoblast Fusion. Image depicts normal myoblast (early muscle cells with a single nucleus) fusing together to form myocytes (multinucleated musle cells) during myogenesis.
